Cite
HARVARD Citation
Park, S. et al. (2021). Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study. Diabetes, obesity & metabolism. 23 (6), pp. 1232-1241. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Park, S. et al. (2021). Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study. Diabetes, obesity & metabolism. 23 (6), pp. 1232-1241. [Online].